Fund opens to boost UK life sciences manufacturing
The £20 million fund will boost the UK’s life sciences manufacturing capabilities, creating new economic opportunities and highly skilled jobs
Read More
Author: Selina McKee
UK rolls out Moderna’s COVID vaccine
The vaccine is the third to be approved for use in the UK to protect against COVID-19
Read More
NICE backs restricted use of Ondexxya
Funding backed for reversal of gastrointestinal bleeds but not for intracranial haemorrhage
Read More
EC approval for Ontozry
The drug offers new hope for epilepsy patients with focal-onset seizures
Read More
Researchers link to facilitate cheaper biologics
The parties intend to develop more cost-effective ways of producing biologic medicines
Read More- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
- Theolytics announces first patient dosed in the Octopod‑IP trial
- UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
- Saphnelo approved in the US for subcutaneous self‑administration
- Transgene completes randomisation in phase 2 trial of tg4050
